Approval · Notice of Compliance 34512 · 2024
EVRA: Notice of Compliance 34512
Issued December 9, 2024
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 34512
- Date
- December 9, 2024
- Company
- Searchlight Pharma Inc.Montreal, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Update to the Product Monograph as per advisement letter. Product Monograph reformatted to the Master Template
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| EVRA | Not yet assigned | — |
Medicinal ingredients
- ETHINYL ESTRADIOL 35 MCG per UNIT
- NORELGESTROMIN 200 MCG per UNIT